Spots Global Cancer Trial Database for fluoropyrimidine
Every month we try and update this database with for fluoropyrimidine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis | NCT03023436 | Stomach Neoplas... | Cytoreductive s... Hyperthermic In... Fluoropyrimidin... Cisplatin | 19 Years - 74 Years | Nanfang Hospital, Southern Medical University | |
BMS-247550 in Treating Patients With Metastatic Colorectal Cancer | NCT00033306 | Colorectal Canc... | ixabepilone Fluoropyrimidin... Irinotecan | 18 Years - | University of Alabama at Birmingham | |
A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma | NCT04257461 | Small Bowel Ade... | Fluoropyrimidin... Oxaliplatin | 18 Years - | Belgian Group of Digestive Oncology | |
A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma | NCT04257461 | Small Bowel Ade... | Fluoropyrimidin... Oxaliplatin | 18 Years - | Belgian Group of Digestive Oncology | |
Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis | NCT03023436 | Stomach Neoplas... | Cytoreductive s... Hyperthermic In... Fluoropyrimidin... Cisplatin | 19 Years - 74 Years | Nanfang Hospital, Southern Medical University | |
Defining Robust Predictors of Chemotherapy Related Cardiotoxicity | NCT05159479 | Cardiotoxicity Gastrointestina... | 18 Years - | University College, London | ||
Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines | NCT01547923 | Colorectal Canc... Intravenous 5 F... | Blood sample fo... Blood sample fo... | 18 Years - | Institut Cancerologie de l'Ouest | |
Effects of S-1 and Capecitabine on Coronary Artery Blood Flow | NCT02216149 | Esophagus Cance... Stomach Cancer Small Bowel Can... Colon Cancer Rectum Cancer | S-1 Capecitabine Oxaliplatin | 18 Years - 100 Years | Helsinki University Central Hospital | |
C677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine Effectiveness in Metastatic Colon Cancer | NCT03852290 | Colon Cancer MTHFR Gene Muta... Chemotherapeuti... Chemotherapy Ef... | 18 Years - | Universidad de Costa Rica | ||
BMS-247550 in Treating Patients With Metastatic Colorectal Cancer | NCT00033306 | Colorectal Canc... | ixabepilone Fluoropyrimidin... Irinotecan | 18 Years - | University of Alabama at Birmingham | |
A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer | NCT04188145 | Metastatic Colo... | Fluoropyrimidin... Bevacizumab | 18 Years - | Centre Hospitalier Universitaire Dijon | |
Effects of S-1 and Capecitabine on Coronary Artery Blood Flow | NCT02216149 | Esophagus Cance... Stomach Cancer Small Bowel Can... Colon Cancer Rectum Cancer | S-1 Capecitabine Oxaliplatin | 18 Years - 100 Years | Helsinki University Central Hospital | |
Cardiotoxicity and Risk Factors in Patients With Colorectal Cancer Receiving Fluoropyrimidine | NCT02665312 | Colorectal Canc... | 18 Years - | Fondazione del Piemonte per l'Oncologia | ||
A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer | NCT04188145 | Metastatic Colo... | Fluoropyrimidin... Bevacizumab | 18 Years - | Centre Hospitalier Universitaire Dijon |